Characteristic of patients | n | NashTest AUROC | Lower 95% | Upper 95% | Prevalence Borderline or NASH | Significance |
---|---|---|---|---|---|---|
All 257 patients | 257 | 0.78 | 0.72 | 0.84 | 0.38 | |
Stratified according to Group* | ||||||
Training Group | 160 | 0.77 | 0.68 | 0.84 | 0.36 | 0.34 |
Validation Group | 97 | 0.83 | 0.67 | 0.90 | 0.42 | |
Stratified according to ALT value* | ||||||
ALT< 50IU/L | 92 | 0.74 | 0.62 | 0.82 | 0.50 | 0.24 |
ALT>= 50 IU/L | 165 | 0.81 | 0.73 | 0.87 | 0.32 | |
Stratified according to Alcohol consumption* | ||||||
None | 95 | 0.78 | 0.67 | 0.86 | 0.37 | 0.83 and 0.20 |
< 30 g for men and < 20 g for female | 150 | 0.77 | 0.66 | 0.84 | 0.39 | 0.83 and 0.19 |
>= 30 g for men or >= 20 g for female | 12 | 1.00 | 0.35 | 1.00 | 0.33 | 0.20 and 0.19 |
Stratified according to Quality of biopsy* | ||||||
< 25 mm | 194 | 0.78 | 0.71 | 0.84 | 0.39 | 0.98 |
>= 25 mm | 63 | 0.78 | 0.63 | 0.88 | 0.37 | |
Fragmented | 148 | 0.77 | 0.68 | 0.84 | 0.36 | 0.46 |
Not Fragmented | 109 | 0.81 | 0.71 | 0.88 | 0.40 | |
Patients included or excluded | ||||||
Patients without steatosis included** | 272 | 0.79 | 0.72 | 0.84 | 0.39 | 0.83 |
High risk of NashTest failures excluded** | ||||||
Gilbert excluded | 244 | 0.78 | 0.71 | 0.83 | 0.39 | 0.97 |
Acute Inflammation excluded | 254 | 0.78 | 0.72 | 0.84 | 0.38 | 0.98 |